|
|
Volumn 29, Issue 1-2, 1997, Pages 1557-1559
|
|
Cost-effective management of acute rejection in liver transplant recipients: A managed care perspective
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
METHYLPREDNISOLONE SODIUM SUCCINATE;
OKT 3;
TACROLIMUS;
THYMOCYTE ANTIBODY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER BIOPSY;
LIVER TRANSPLANTATION;
MANAGED CARE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
ACUTE DISEASE;
ANTILYMPHOCYTE SERUM;
BIOPSY, NEEDLE;
COST-BENEFIT ANALYSIS;
CYCLOSPORINE;
GRAFT REJECTION;
HUMANS;
HYPERGLYCEMIA;
IMMUNOSUPPRESSION;
LIVER TRANSPLANTATION;
MANAGED CARE PROGRAMS;
METHYLPREDNISOLONE HEMISUCCINATE;
MUROMONAB-CD3;
OUTPATIENTS;
UNITED STATES;
|
|
EID: 0030962630
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00673-2 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (7)
|
